Results 101 to 110 of about 491,136 (305)
ABO(H) blood groups and vascular disease: a systematic review and meta-analysis [PDF]
<i>Background</i>: Associations between vascular disease and ABO(H) blood groups have a long history, but no consensus exists regarding its magnitude and significance, or whether it relates to all disorders equally. An accurate calculation of
O. WU +7 more
core +1 more source
A bioactive poly(citrate‐polyglycol‐procyanidin) (PCGP) nanoshield is developed for cardiovascular implants to restore endothelial mitochondrial homeostasis following vascular injury. By preserving mitochondrial integrity, re‐establishing metabolic balance, and activating PI3K/Akt/eNOS‐NO signaling, the PCGP interface promotes functional endothelial ...
Xiyu Liu +14 more
wiley +1 more source
Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis
Sepsis triggers a significant increase in IL‐39 production, with circulating levels markedly elevated and positively correlated with disease severity and poor clinical prognosis in sepsis patients. Mechanistically, macrophage‐derived IL‐39 activates the GP130 signaling pathway via a ligand‐receptor interaction, thereby fueling the pro‐inflammatory ...
Feng‐zhi Zhang +9 more
wiley +1 more source
Cancer and risk of cerebral venous thrombosis: a case-control study
Background: Cancer is an established risk factor for leg vein thrombosis and pulmonary embolism. Controlled studies assessing the risk of cerebral venous thrombosis (CVT) in patients with cancer have not been performed.
Zuurbier, S. M. +19 more
core +1 more source
Sepsis‑induced pediatric acute respiratory distress syndrome suppresses FOXF1 in lung endothelial cells which causes life‐threatening lung damage. To counter this, researchers developed nanoparticles that specifically target these cells and deliver FOXF1 mRNA.
Zicheng Deng +14 more
wiley +1 more source
Superficial venous thrombosis: disease progression and evolving treatment approaches
Maria E Litzendorf, Bhagwan SatianiHeart and Vascular Center and Division of Vascular Surgery, Department of Surgery, The Ohio State University College of Medicine, Columbus, OH, USAAbstract: Treatment of superficial venous thrombosis (SVT) has recently ...
Litzendorf M
core
A light‐activated catheter insert combines antimicrobial blue light with nitric oxide release to generate complementary oxidative and nitrosative stress, producing potent broad‐spectrum antimicrobial activity. The approach achieves greater than 4‐log reductions in bacterial and fungal viability and significantly reduces Staphylococcus aureus ...
Alexander Bruckmann +7 more
wiley +1 more source
Venous and arterial thrombosis: Two aspects of the same disease?
Paolo PrandoniDepartment of Cardiothoracic and Vascular Sciences, Thromboembolism Unit, University Hospital of Padua Padua, ItalyAbstract: An increasing body of evidence suggests the likelihood of a link between venous and arterial thrombosis.
Paolo Prandoni
core
An engineered peptide self‐assembled nanofiber platform, designed to replicate STING–cGAMP binding motifs, facilitates pH‐responsive cytosolic delivery of cGAMP, enhances the endoplasmic reticulum with high efficiency, and robustly activates the STING pathway.
Yubin He +6 more
wiley +1 more source
Factors associated with venous collaterals in patients with cerebral venous thrombosis.
ObjectivesTo identify the factors associated with venous collaterals in Thai patients with cerebral venous thrombosis.Materials and methodsThis retrospective 20-year cohort study enrolled patients diagnosed with cerebral venous thrombosis between January
Phirat Petchprom +6 more
doaj +1 more source

